Compare the Efficacy and Safety of Metformin/Rosuvastatin Combination Therapy With Metformin or Rosuvastatin Monotherapy in Patients With Type 2 Diabetes and Dyslipidemia
Multi-center, Randomized, Double-blind, Phase III clinical trial
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
237
Group I: Metformin + Rosuvastatin,
Group II: Metformin + placebo,
Group III: placebo + Rosuvastatin
LDL-C (% change)
Time frame: 16 weeks from baseline
change of HbA1c
Time frame: 16 weeks from baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Buchoen St. mary's Hospital
Bucheon-si, South Korea
SeJong Hostpital
Bucheon-si, South Korea
SoonChunHyang University Bucheon Hospital
Bucheon-si, South Korea
InJe University Busan paik Hospital
Busan, South Korea
Inje University Haeundae paik hospital
Busan, South Korea
Daegu Catholic University Medical Center
Daegu, South Korea
Youngnam University Hostpital
Daegu, South Korea
Daeheon Eulji Medical Center
Daejeon, South Korea
KonYang University Hostpital
Daejeon, South Korea
Chosun University Hospital
Gwangju, South Korea
...and 23 more locations